Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Psychosis”

180 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 180 results

Testing effectiveness (Phase 2)Ended earlyNCT00570063
What this trial is testing

Double Blind, Randomized, 3 Week Inpatient Study To Evaluate The Safety & Efficacy Of PF-02545920 Compared With Placebo

Who this might be right for
Schizophrenia
Pfizer 35
Testing effectiveness (Phase 2)Study completedNCT00694707
What this trial is testing

Safety and Efficacy of Cariprazine (RGH-188) in the Acute Exacerbation of Schizophrenia

Who this might be right for
Schizophrenia
Forest Laboratories 732
Testing effectiveness (Phase 2)Study completedNCT03055338
What this trial is testing

An Active-Controlled Early Phase Study of MK-8189 in Adults With Schizophrenia (MK-8189-005)

Who this might be right for
Schizophrenia, Acute Episode
Merck Sharp & Dohme LLC 224
Large-scale testing (Phase 3)Ended earlyNCT00486798
What this trial is testing

FAST-A Study to Evaluate the Efficacy and Safety of Quetiapin IR in Patients With Acute Psychosis

Who this might be right for
Psychotic DisordersSchizophreniaBipolar Disorder
AstraZeneca
Not applicableStudy completedNCT00399334
What this trial is testing

PROFILe3: Epidemiologic Survey in Patients With Schizophrenia or Schizoaffective Disorders

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder
Janssen-Cilag, S.A. 1,607
Post-approval studies (Phase 4)Study completedNCT00954122
What this trial is testing

Efficacy and Safety of SEROQUEL Extended Release (XR) in Acute Schizophrenia

Who this might be right for
Schizophrenia
AstraZeneca 35
Large-scale testing (Phase 3)Study completedNCT00460512
What this trial is testing

An Efficacy, Safety And Tolerability Study of Flexibly Dosed Paliperidone Extended Release (ER) in Participants With Schizophrenia

Who this might be right for
Schizophrenia
Janssen-Cilag International NV 1,814
Testing effectiveness (Phase 2)Study completedNCT04624243
What this trial is testing

Efficacy and Safety of MK-8189 in Participants With an Acute Episode of Schizophrenia (MK-8189-008)

Who this might be right for
Schizophrenia
Merck Sharp & Dohme LLC 499
Large-scale testing (Phase 3)Study completedNCT01625000
What this trial is testing

Safety and Efficacy of MP-214 in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Tanabe Pharma Corporation 512
Large-scale testing (Phase 3)Study completedNCT00637234
What this trial is testing

Oxcarbazepine as an Adjunct of Antipsychotic Therapy in Acute Schizophrenia

Who this might be right for
Schizophrenia
University of Cologne 54
Post-approval studies (Phase 4)Study completedNCT00779506
What this trial is testing

Study of the Efficacy and Safety of Quetiapine Fumarate Extended Release (Seroquel XR)

Who this might be right for
Schizophrenia
AstraZeneca 96
Not applicableLooking for participantsNCT07364825
What this trial is testing

Acute Psychiatric Care at Home for Lower-risk Patients With Acute Psychiatric Illness Who Require Inpatient Care

Who this might be right for
PsychosisAnxietyDepression+1 more
Brigham and Women's Hospital 45
Not applicableStudy completedNCT01622166
What this trial is testing

Art Therapy in Acute Schizophrenia

Who this might be right for
Schizophrenia
Charite University, Berlin, Germany 60
Not applicableStudy completedNCT05633108
What this trial is testing

A Study Based on the French National Health Insurance Database in Participants With Psychotic Disorders

Who this might be right for
Psychotic Disorders
Eisai Co., Ltd. 579,728
Large-scale testing (Phase 3)Study completedNCT00334126
What this trial is testing

Evaluation of Effectiveness and Safety of Paliperidone ER (Extended-release) Compared With Quetiapine in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 399
Large-scale testing (Phase 3)Study completedNCT00645372
What this trial is testing

Compare the Efficacy and Safety of Ziprasidone and Risperidone for the Treatment of Schizophrenia in Chinese Patients

Who this might be right for
Schizophrenia
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 242
Large-scale testing (Phase 3)Study completedNCT00136994
What this trial is testing

IM and Oral in Acute Exacerbation of Schizophrenia (BIZET Study)

Who this might be right for
Schizophrenia
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 160
Testing effectiveness (Phase 2)Study completedNCT01490086
What this trial is testing

RP5063 in Subjects With Schizophrenia or Schizoaffective Disorder

Who this might be right for
Acute SchizophreniaSchizoaffective Disorder
Reviva Pharmaceuticals 234
Post-approval studies (Phase 4)Study completedNCT01527305
What this trial is testing

Evaluate the Effectiveness and Safety of Paliperidone Palmitate in Subjects With Acute Schizophrenia

Who this might be right for
Schizophrenia
Janssen Research & Development, LLC 212
Testing effectiveness (Phase 2)Study completedNCT00102479
What this trial is testing

Aripiprazole Pharmacokinetics (PK) and Tolerability Study in Children and Adolescents

Who this might be right for
SchizophreniaMania
Otsuka Pharmaceutical Development & Commercialization, Inc.
Load More Results